Cinacalcet for Management of Tertiary Hyperparathyroidism Associated with Chronic Treatment of Hypophosphatemia in an Adult with Tumor-Induced Osteomalacia

Cinacalcet for Management of Tertiary Hyperparathyroidism Associated with Chronic Treatment of Hypophosphatemia in an Adult with Tumor-Induced Osteomalacia

ABSTRACT: Objective: To report the effectiveness of cinacalcet in treating tertiary hyperparathyroidism (THPT) associated with chronic treatment of hypophosphatemia in a patient with fibroblast growth factor-23 (FGF-23)-mediated tumor-induced osteomalacia (TIO).Methods: We review the clinical course...

Full description

Bibliographic Details
Main Authors:	Sophia Hu, MD, Seena C. Aisner, MD, Sara E. Lubitz, MD
Format:	Article
Language:	English
Published:	Elsevier 2015-01-01
Series:	AACE Clinical Case Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2376060520303370

Similar Items

Circulating sclerostin in adult patients with tumor-induced osteomalacia comparing with X-linked hypophosphatemia
by: Xiaolin Ni, et al.
Published: (2021-04-01)

Cinacalcet effect on severe hyperparathyroidism
by: Al Saran Khalid, et al.
Published: (2010-01-01)

Burosumab - new potent treatment for X-linked hypophosphatemia and tumor-induced osteomalacia
by: Magda Wojtuś, et al.
Published: (2023-07-01)

Role of cinacalcet in the treatment of secondary hyperparathyroidism in chronic kidney disease
by: H.K. Aggarwal, et al.
Published: (2013-09-01)

CINACALCET IN TREATMENT OF HYPERPARATHYROIDISM IN RECIPIENTS OF RENAL GRAFT
by: O. N. Vetchinnikova, et al.
Published: (2014-05-01)

Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia
by: Kate Hawke, et al.
Published: (2024-02-01)

Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report
by: Eeva M. Ryhänen, et al.
Published: (2021-06-01)

Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function
by: Son Nguyen DO, PharmD, et al.
Published: (2020-06-01)

Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis.
by: Ariadna Pérez-Ricart, et al.
Published: (2016-01-01)

THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Sungjin Chung, et al.
Published: (2012-06-01)

Cinacalcet in treatment of the secondary hyperparathyroidism relapse in patients on dialysis
by: Olga Vetchinnikova, et al.
Published: (2012-06-01)

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
by: Giulia Di Dalmazi, et al.
Published: (2018-12-01)

Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study
by: Suyun Jung, et al.
Published: (2022-07-01)

Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia
by: Juan M. Colazo, BSc, et al.
Published: (2021-06-01)

PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET
by: R. I. Yagudina, et al.
Published: (2015-03-01)

The conundrum of parathyroidectomy vs cinacalcet for treatment of post-transplant hyperparathyroidism
by: Rima Patel, et al.
Published: (2020-08-01)

Tumor-Induced Osteomalacia Localized and Excised After Pregnancy
by: Melissa Sum, MD, et al.
Published: (2021-11-01)

High bone turnover and hyperparathyroidism after surgery for tumor-induced osteomalacia: A case series
by: Mark T. Kilbane, et al.
Published: (2021-12-01)

Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease
by: Daniela Ponce, et al.
Published: (2023-04-01)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
by: Ariadna Pérez-Ricart, et al.
Published: (2019-06-01)

Phosphaturic Mesenchymal Heel Tumor Presenting with Tumor-Induced Osteomalacia
by: Tarandeep Kaur, MD, et al.
Published: (2019-03-01)

Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcet
by: Muhammed Ahmed Elhadedy, et al.
Published: (2023-04-01)

Cinacalcet for Severe Secondary Hyperparathyroidism in Children with End-stage Kidney Disease
by: Areej Adel Sheerah, et al.
Published: (2021-01-01)

Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation
by: Soliman Amin R., et al.
Published: (2016-09-01)

A single-centre retrospective analysis of cinacalcet therapy in primary hyperparathyroidism
by: Daniel Bell, et al.
Published: (2021-11-01)

Experience with cinacalcet in primary hyperparathyroidism: results after 1 year of treatment
by: Inés Luque-Fernández, et al.
Published: (2013-06-01)

Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure
by: José M. Orellana, et al.
Published: (2016-03-01)

A Case of Hypophosphatemia due to Oncogenic Osteomalacia in a Patient with Natural Killer T-Cell Lymphoma
by: Guoliang Zheng, et al.
Published: (2021-07-01)

Bone Volumetric Density, Microarchitecture, and Estimated Bone Strength in Tumor-Induced Rickets/Osteomalacia Versus X-linked Hypophosphatemia in Chinese Adolescents
by: Ruizhi Jiajue, et al.
Published: (2022-06-01)

The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
by: Paweena Susantitaphong, et al.
Published: (2019-01-01)

Tumor-induced osteomalacia
by: Pablo Florenzano, et al.
Published: (2017-12-01)

Tumor-induced osteomalacia
by: Zinan Yin, et al.
Published: (2018-12-01)

A Case of Tumor-Induced Osteomalacia Associated with an Organizing Hematoma
by: Seong Hee Ahn, MD, PhD, et al.
Published: (2018-03-01)

The Effectiveness of Alternate-day Cinacalcet Therapy for Secondary Hyperparathyroidism in Noncompliant Hemodialysis Patients
by: Mohammed Al-Homrany, et al.
Published: (2022-01-01)

Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review
by: Xiaosong Li, et al.
Published: (2023-07-01)

The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism
by: Sérgio Gardano Elias Bucharles, et al.

Skeletal blood flow measured with 18F in patients with osteomalacia and hyperparathyroidism.
by: Tellez, M, et al.
Published: (1983)

Tumor-Induced Osteomalacia due to Hitherto Undiagnosed Subcutaneous Phosphaturic Mesenchymal Tumor
by: Raiz Ahmad Misgar, MBBS, MD, DM, et al.
Published: (2018-05-01)

Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
by: Keiichi Otsuka, et al.
Published: (2018-10-01)

Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience
by: Julie Bernardor, et al.
Published: (2022-08-01)